Skip to content
1887

Microbial Genomics logo Microbial Genomics

Volume 11, Issue 2

Mutations in the riboflavin biosynthesis pathway confer resistance to furazolidone and abolish the synergistic interaction between furazolidone and vancomycin in Open Access

Abstract

The combined application of furazolidone and vancomycin has previously been shown to be synergistic against Gram-negative pathogens, with great therapeutic promise. However, the emergence and mechanism of resistance to this antibiotic combination have not been characterized. To fill this gap, we here selected progeny for growth on the furazolidone–vancomycin combination at the concentration where the parent was sensitive. We show that selected clones were associated with increased resistance to neither, only one drug, or both furazolidone and vancomycin, but in all cases were associated with a decrease in the growth inhibition synergy. Using whole-genome sequencing, we identified various gene mutations in the resistant mutants. We further investigated the mechanism behind the most frequently arising mutations, those in the riboflavin biosynthesis genes and , that represent novel mutations causing furazolidone resistance and diminished vancomycin–furazolidone synergy. It was found that these mutations act predominantly by decreasing the activity of the NfsA and NfsB nitroreductases. The emergence of the / mutations imposes a significant fitness cost on bacterial growth. Surprisingly, supplementing the medium with riboflavin, which compensates for the affected riboflavin biosynthesis pathway, could restore the normal growth of the / mutants while having no effects on the furazolidone resistance phenotype. Searching the mutations in the public sequencing database detects the presence of the furazolidone-resistance-conferring mutations (TKAG deletion or duplication) in clinical isolates from different countries. Hypotheses explaining why these mutations were found in clinical isolates despite having poor fitness were further discussed.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): antibiotic resistance , furazolidone , riboflavin , vancomycin and synergy
Funding
This study was supported by the:
  • Massey University-MBIE PSAF II (Award MU001985)
    • Principal Award Recipient: JasnaRakonjac
© 2025 The Authors
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License. This article was made open access via a Publish and Read agreement between the Microbiology Society and the corresponding author’s institution.
Loading

Article metrics loading...

/content/journal/mgen/10.1099/mgen.0.001356
2025-02-11
2026-04-19

Metrics

Loading full text...

Full text loading...

/deliver/fulltext/mgen/11/2/mgen001356.html?itemId=/content/journal/mgen/10.1099/mgen.0.001356&mimeType=html&fmt=ahah

References

  1. Sun W, Sanderson PE, Zheng W. Drug combination therapy increases successful drug repositioning. Drug Discov Today 2016; 21:1189–1195 [View Article] [PubMed]
     [Google Scholar]
  2. Urban C, Mariano N, Rahal JJ. In vitro double and triple bactericidal activities of doripenem, polymyxin B, and rifampin against multidrug-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli. Antimicrob Agents Chemother 2010; 54:2732–2734 [View Article] [PubMed]
     [Google Scholar]
  3. Chevereau G, Bollenbach T. Systematic discovery of drug interaction mechanisms. Mol Syst Biol 2015; 11:807 [View Article] [PubMed]
     [Google Scholar]
  4. Le VVH, Olivera C, Spagnuolo J, Davies IG, Rakonjac J. In vitro synergy between sodium deoxycholate and furazolidone against enterobacteria. BMC Microbiol 2020; 20:5 [View Article] [PubMed]
     [Google Scholar]
  5. Olivera C, Le VVH, Davenport C, Rakonjac J. In vitro synergy of 5-nitrofurans, vancomycin and sodium deoxycholate against gram-negative pathogens. J Med Microbiol 2021; 70:001304 [View Article] [PubMed]
     [Google Scholar]
  6. Thomason LC, Costantino N, Court DL. E. coli genome manipulation by P1 transduction. Curr Protoc Mol Biol 2007; Chapter 1:1 [View Article] [PubMed]
     [Google Scholar]
  7. Baba T, Ara T, Hasegawa M, Takai Y, Okumura Y et al. Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol Syst Biol 2006; 2:2006–2008 [View Article] [PubMed]
     [Google Scholar]
  8. Datsenko KA, Wanner BL. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci USA 2000; 97:6640–6645 [View Article]
     [Google Scholar]
  9. Kitagawa M, Ara T, Arifuzzaman M, Ioka-Nakamichi T, Inamoto E et al. Complete set of ORF clones of Escherichia coli ASKA library (a complete set of E. coli K-12 ORF archive): unique resources for biological research. DNA Res 2005; 12:291–299 [View Article] [PubMed]
     [Google Scholar]
  10. Cockerill FR, Wikler MA, Alder J, Dudley MN, Eliopoulos GM et al. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard— Ninth Edition Clinical and Laboratory Standards Institute (CLSI), Institute CaLS; 2012
     [Google Scholar]
  11. Campbell J. High-throughput assessment of bacterial growth inhibition by optical density measurements. Curr Protoc Chem Biol 2010; 2:195–208 [View Article] [PubMed]
     [Google Scholar]
  12. Odds FC. Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother 2003; 52:1 [View Article] [PubMed]
     [Google Scholar]
  13. Cox MP, Peterson DA, Biggs PJ. SolexaQA: at-a-glance quality assessment of Illumina second-generation sequencing data. BMC Bioinf 2010; 11:1–6 [View Article] [PubMed]
     [Google Scholar]
  14. Grenier F, Matteau D, Baby V, Rodrigue S. Complete genome sequence of Escherichia coli BW25113. Genome Announc 2014; 2:e01038-14 [View Article] [PubMed]
     [Google Scholar]
  15. Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods 2012; 9:357–359 [View Article] [PubMed]
     [Google Scholar]
  16. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J et al. The sequence alignment/Map format and SAMtools. Bioinformatics 2009; 25:2078–2079 [View Article] [PubMed]
     [Google Scholar]
  17. Garrison E, Marth G. Haplotype-based variant detection from short-read sequencing; 2012; arXiv preprint arXiv12073907
  18. Cingolani P, Platts A, Wang LL, Coon M, Nguyen T et al. A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly 2012; 6:80–92 [View Article] [PubMed]
     [Google Scholar]
  19. Bankevich A, Nurk S, Antipov D, Gurevich AA, Dvorkin M et al. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol 2012; 19:455–477 [View Article] [PubMed]
     [Google Scholar]
  20. Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 1997; 25:3389–3402 [View Article] [PubMed]
     [Google Scholar]
  21. Howe JA, Wang H, Fischmann TO, Balibar CJ, Xiao L et al. Selective small-molecule inhibition of an RNA structural element. Nature 2015; 526:672–677 [View Article] [PubMed]
     [Google Scholar]
  22. Darty K, Denise A, Ponty Y. VARNA: interactive drawing and editing of the RNA secondary structure. Bioinformatics 2009; 25:1974–1975 [View Article] [PubMed]
     [Google Scholar]
  23. Mirdita M, Schütze K, Moriwaki Y, Heo L, Ovchinnikov S et al. ColabFold: making protein folding accessible to all. Nat Methods 2022; 19:679–682 [View Article] [PubMed]
     [Google Scholar]
  24. Le VVH, Davies IG, Moon CD, Wheeler D, Biggs PJ et al. Novel 5-nitrofuran-activating reductase in Escherichia coli. Antimicrob Agents Chemother 2019; 63:e00868–00819 [View Article]
     [Google Scholar]
  25. Morgulis A, Coulouris G, Raytselis Y, Madden TL, Agarwala R et al. Database indexing for production MegaBLAST searches. Bioinformatics 2008; 24:1757–1764 [View Article] [PubMed]
     [Google Scholar]
  26. Ye J, Coulouris G, Zaretskaya I, Cutcutache I, Rozen S et al. Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction. BMC Bioinf 2012; 13:134 [View Article] [PubMed]
     [Google Scholar]
  27. Alcock BP, Huynh W, Chalil R, Smith KW, Raphenya AR et al. CARD 2023: expanded curation, support for machine learning, and resistome prediction at the comprehensive antibiotic resistance database. Nucleic Acids Res 2023; 51:D690–D699 [View Article] [PubMed]
     [Google Scholar]
  28. Zenno S, Koike H, Kumar AN, Jayaraman R, Tanokura M et al. Biochemical characterization of NfsA, the Escherichia coli major nitroreductase exhibiting a high amino acid sequence homology to Frp, a Vibrio harveyi flavin oxidoreductase. J Bacteriol 1996; 178:4508–4514 [View Article] [PubMed]
     [Google Scholar]
  29. Zenno S, Koike H, Tanokura M, Saigo K. Gene cloning, purification, and characterization of NfsB, a minor oxygen-insensitive nitroreductase from Escherichia coli, similar in biochemical properties to FRase I, the major flavin reductase in Vibrio fischeri. J Biochem 1996; 120:736–744 [View Article] [PubMed]
     [Google Scholar]
  30. Pedrolli D, Langer S, Hobl B, Schwarz J, Hashimoto M et al. The ribB FMN riboswitch from Escherichia coli operates at the transcriptional and translational level and regulates riboflavin biosynthesis. FEBS J 2015; 282:3230–3242 [View Article] [PubMed]
     [Google Scholar]
  31. Averianova LA, Balabanova LA, Son OM, Podvolotskaya AB, Tekutyeva LA. Production of vitamin B2 (Riboflavin) by microorganisms: an overview. Front Bioeng Biotechnol 2020; 8:570828 [View Article] [PubMed]
     [Google Scholar]
  32. Olivera C, Cox MP, Rowlands GJ, Rakonjac J. Correlated transcriptional responses provide insights into the synergy mechanisms of the furazolidone, vancomycin, and sodium deoxycholate triple combination in Escherichia coli. mSphere 2021; 6:e0062721 [View Article] [PubMed]
     [Google Scholar]
  33. Bittner L-M, Arends J, Narberhaus F. When, how and why? regulated proteolysis by the essential FtsH protease in Escherichia coli. Biol Chem 2017; 398:625–635 [View Article] [PubMed]
     [Google Scholar]
  34. Hari SB, Morehouse JP, Baker TA, Sauer RT. FtsH degrades kinetically stable dimers of cyclopropane fatty acid synthase via an internal degron. Mol Microbiol 2023; 119:101–111 [View Article] [PubMed]
     [Google Scholar]
  35. Morehouse JP, Baker TA, Sauer RT. FtsH degrades dihydrofolate reductase by recognizing a partially folded species. Protein Sci 2022; 31:e4410 [View Article] [PubMed]
     [Google Scholar]
  36. Mörtl S, Fischer M, Richter G, Tack J, Weinkauf S et al. Biosynthesis of riboflavin: lumazine synthase of Escherichia coli. J Biol Chem 1996; 271:33201–33207 [View Article]
     [Google Scholar]
  37. Ritsert K, Huber R, Turk D, Ladenstein R, Schmidt-Bäse K et al. Studies on the lumazine synthase/riboflavin synthase complex of Bacillus subtilis: crystal structure analysis of reconstituted, icosahedral beta-subunit capsids with bound substrate analogue inhibitor at 2.4 A resolution. J Mol Biol 1995; 253:151–167 [View Article] [PubMed]
     [Google Scholar]
  38. Vervoort J, Xavier BB, Stewardson A, Coenen S, Godycki-Cwirko M et al. An in vitro deletion in ribE encoding lumazine synthase contributes to nitrofurantoin resistance in Escherichia coli. Antimicrob Agents Chemother 2014; 58:7225–7233 [View Article]
     [Google Scholar]
  39. Ho P-L, Ng K-Y, Lo W-U, Law PY, Lai EL-Y et al. Plasmid-mediated oqxAB is an important mechanism for nitrofurantoin resistance in Escherichia coli. Antimicrob Agents Chemother 2016; 60:537–543 [View Article]
     [Google Scholar]
  40. Wan Y, Mills E, Leung RCY, Vieira A, Zhi X et al. Alterations in chromosomal genes nfsA, nfsB, and ribE are associated with nitrofurantoin resistance in Escherichia coli from the United Kingdom. Microb Genom 2021; 7: [View Article]
     [Google Scholar]
  41. Khamari B, Adak S, Chanakya PP, Lama M, Peketi ASK et al. Prediction of nitrofurantoin resistance among Enterobacteriaceae and mutational landscape of in vitro selected resistant Escherichia coli. Res Microbiol 2022; 173:103889 [View Article] [PubMed]
     [Google Scholar]
  42. Merrill AH, McCormick DB. Riboflavin. In Marriott BP, Birt DF, Stallings VA, AA Y. eds Present Knowledge in Nutrition Academic Press; 2020 pp 189–207
     [Google Scholar]
  43. Baba T, Ara T, Hasegawa M, Takai Y, Okumura Y et al. Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol Syst Biol 2006; 2:2006.0008 [View Article] [PubMed]
     [Google Scholar]
  44. Cherepanov PP, Wackernagel W. Gene disruption in Escherichia coli: TcR and KmR cassettes with the option of Flp-catalyzed excision of the antibiotic-resistance determinant. Gene 1995; 158:9–14 [View Article] [PubMed]
     [Google Scholar]
/content/journal/mgen/10.1099/mgen.0.001356
Loading
Mutations in the riboflavin biosynthesis pathway confer resistance to furazolidone and abolish the synergistic interaction between furazolidone and vancomycin in Escherichia coli
M Gen 11, 001356 (2025); https://doi.org/10.1099/mgen.0.001356
/content/journal/mgen/10.1099/mgen.0.001356
/content/journal/mgen/10.1099/mgen.0.001356
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An error occurred
Approval was partially successful, following selected items could not be processed due to error